Table of Contents 1 Erectile Dysfunction Drugs Market Overview 1.1 Product Overview and Scope of Erectile Dysfunction Drugs 1.2 Erectile Dysfunction Drugs Segment by Type 1.2.1 Global Erectile Dysfunction Drugs Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 Sildenafil 1.2.3 Tadalafil 1.2.4 Others 1.3 Erectile Dysfunction Drugs Segment by Application 1.3.1 Erectile Dysfunction Drugs Sales Comparison by Application: 2020 VS 2026 1.3.2 Hospital Pharmacies 1.3.3 Private Clinics 1.3.4 Retail Pharmacies 1.3.5 E-Commerce (B2B) 1.3.6 E-Commerce (B2C) 1.4 Global Erectile Dysfunction Drugs Market Size Estimates and Forecasts 1.4.1 Global Erectile Dysfunction Drugs Revenue 2015-2026 1.4.2 Global Erectile Dysfunction Drugs Sales 2015-2026 1.4.3 Erectile Dysfunction Drugs Market Size by Region: 2020 Versus 2026 2 Global Erectile Dysfunction Drugs Market Competition by Manufacturers 2.1 Global Erectile Dysfunction Drugs Sales Market Share by Manufacturers (2015-2020) 2.2 Global Erectile Dysfunction Drugs Revenue Share by Manufacturers (2015-2020) 2.3 Global Erectile Dysfunction Drugs Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Erectile Dysfunction Drugs Manufacturing Sites, Area Served, Product Type 2.5 Erectile Dysfunction Drugs Market Competitive Situation and Trends 2.5.1 Erectile Dysfunction Drugs Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key Erectile Dysfunction Drugs Players (Opinion Leaders) 3 Erectile Dysfunction Drugs Retrospective Market Scenario by Region 3.1 Global Erectile Dysfunction Drugs Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global Erectile Dysfunction Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America Erectile Dysfunction Drugs Market Facts & Figures by Country 3.3.1 North America Erectile Dysfunction Drugs Sales by Country 3.3.2 North America Erectile Dysfunction Drugs Sales by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Erectile Dysfunction Drugs Market Facts & Figures by Country 3.4.1 Europe Erectile Dysfunction Drugs Sales by Country 3.4.2 Europe Erectile Dysfunction Drugs Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Erectile Dysfunction Drugs Market Facts & Figures by Region 3.5.1 Asia Pacific Erectile Dysfunction Drugs Sales by Region 3.5.2 Asia Pacific Erectile Dysfunction Drugs Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Erectile Dysfunction Drugs Market Facts & Figures by Country 3.6.1 Latin America Erectile Dysfunction Drugs Sales by Country 3.6.2 Latin America Erectile Dysfunction Drugs Sales by Country 3.6.3 Mexico 3.6.3 Brazil 3.6.3 Argentina 3.7 Middle East and Africa Erectile Dysfunction Drugs Market Facts & Figures by Country 3.7.1 Middle East and Africa Erectile Dysfunction Drugs Sales by Country 3.7.2 Middle East and Africa Erectile Dysfunction Drugs Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Erectile Dysfunction Drugs Historic Market Analysis by Type 4.1 Global Erectile Dysfunction Drugs Sales Market Share by Type (2015-2020) 4.2 Global Erectile Dysfunction Drugs Revenue Market Share by Type (2015-2020) 4.3 Global Erectile Dysfunction Drugs Price Market Share by Type (2015-2020) 4.4 Global Erectile Dysfunction Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Erectile Dysfunction Drugs Historic Market Analysis by Application 5.1 Global Erectile Dysfunction Drugs Sales Market Share by Application (2015-2020) 5.2 Global Erectile Dysfunction Drugs Revenue Market Share by Application (2015-2020) 5.3 Global Erectile Dysfunction Drugs Price by Application (2015-2020) 6 Company Profiles and Key Figures in Erectile Dysfunction Drugs Business 6.1 Eli Lilly 6.1.1 Corporation Information 6.1.2 Eli Lilly Description, Business Overview and Total Revenue 6.1.3 Eli Lilly Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2015-2020) 6.1.4 Eli Lilly Products Offered 6.1.5 Eli Lilly Recent Development 6.2 Pfizer 6.2.1 Pfizer Erectile Dysfunction Drugs Production Sites and Area Served 6.2.2 Pfizer Description, Business Overview and Total Revenue 6.2.3 Pfizer Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2015-2020) 6.2.4 Pfizer Products Offered 6.2.5 Pfizer Recent Development 6.3 Bayer 6.3.1 Bayer Erectile Dysfunction Drugs Production Sites and Area Served 6.3.2 Bayer Description, Business Overview and Total Revenue 6.3.3 Bayer Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2015-2020) 6.3.4 Bayer Products Offered 6.3.5 Bayer Recent Development 6.4 BaiYunShan General Factory 6.4.1 BaiYunShan General Factory Erectile Dysfunction Drugs Production Sites and Area Served 6.4.2 BaiYunShan General Factory Description, Business Overview and Total Revenue 6.4.3 BaiYunShan General Factory Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2015-2020) 6.4.4 BaiYunShan General Factory Products Offered 6.4.5 BaiYunShan General Factory Recent Development 6.5 S.K. Chemicals 6.5.1 S.K. Chemicals Erectile Dysfunction Drugs Production Sites and Area Served 6.5.2 S.K. Chemicals Description, Business Overview and Total Revenue 6.5.3 S.K. Chemicals Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2015-2020) 6.5.4 S.K. Chemicals Products Offered 6.5.5 S.K. Chemicals Recent Development 6.6 Teva Pharma 6.6.1 Teva Pharma Erectile Dysfunction Drugs Production Sites and Area Served 6.6.2 Teva Pharma Description, Business Overview and Total Revenue 6.6.3 Teva Pharma Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2015-2020) 6.6.4 Teva Pharma Products Offered 6.6.5 Teva Pharma Recent Development 6.7 Dong-A ST 6.6.1 Dong-A ST Erectile Dysfunction Drugs Production Sites and Area Served 6.6.2 Dong-A ST Description, Business Overview and Total Revenue 6.6.3 Dong-A ST Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Dong-A ST Products Offered 6.7.5 Dong-A ST Recent Development 6.8 Metuchen Pharma 6.8.1 Metuchen Pharma Erectile Dysfunction Drugs Production Sites and Area Served 6.8.2 Metuchen Pharma Description, Business Overview and Total Revenue 6.8.3 Metuchen Pharma Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2015-2020) 6.8.4 Metuchen Pharma Products Offered 6.8.5 Metuchen Pharma Recent Development 6.9 Seoul Pharma 6.9.1 Seoul Pharma Erectile Dysfunction Drugs Production Sites and Area Served 6.9.2 Seoul Pharma Description, Business Overview and Total Revenue 6.9.3 Seoul Pharma Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2015-2020) 6.9.4 Seoul Pharma Products Offered 6.9.5 Seoul Pharma Recent Development 6.10 CSBIO. 6.10.1 CSBIO. Erectile Dysfunction Drugs Production Sites and Area Served 6.10.2 CSBIO. Description, Business Overview and Total Revenue 6.10.3 CSBIO. Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2015-2020) 6.10.4 CSBIO. Products Offered 6.10.5 CSBIO. Recent Development 7 Erectile Dysfunction Drugs Manufacturing Cost Analysis 7.1 Erectile Dysfunction Drugs Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Erectile Dysfunction Drugs 7.4 Erectile Dysfunction Drugs Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Erectile Dysfunction Drugs Distributors List 8.3 Erectile Dysfunction Drugs Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global Erectile Dysfunction Drugs Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Erectile Dysfunction Drugs by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Erectile Dysfunction Drugs by Type (2021-2026) 10.2 Erectile Dysfunction Drugs Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Erectile Dysfunction Drugs by Application (2021-2026) 10.2.2 Global Forecasted Revenue of Erectile Dysfunction Drugs by Application (2021-2026) 10.3 Erectile Dysfunction Drugs Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Erectile Dysfunction Drugs by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Erectile Dysfunction Drugs by Region (2021-2026) 10.4 North America Erectile Dysfunction Drugs Estimates and Projections (2021-2026) 10.5 Europe Erectile Dysfunction Drugs Estimates and Projections (2021-2026) 10.6 Asia Pacific Erectile Dysfunction Drugs Estimates and Projections (2021-2026) 10.7 Latin America Erectile Dysfunction Drugs Estimates and Projections (2021-2026) 10.8 Middle East and Africa Erectile Dysfunction Drugs Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Erectile Dysfunction Drugs Sales (M Pill) Growth Rate Comparison by Type (2015-2026) Table 2. Global Erectile Dysfunction Drugs Sales (M Pill) Comparison by Application: 2020 VS 2026 Table 3. Global Erectile Dysfunction Drugs Market Size by Type (M Pill) (US$ Million) (2020 VS 2026) Table 4. Global Key Erectile Dysfunction Drugs Manufacturers Covered in This Study Table 5. Global Erectile Dysfunction Drugs Sales (M Pill) by Manufacturers (2015-2020) Table 6. Global Erectile Dysfunction Drugs Sales Share by Manufacturers (2015-2020) Table 7. Global Erectile Dysfunction Drugs Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Erectile Dysfunction Drugs Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Erectile Dysfunction Drugs Average Price (USD/Pill) of Key Manufacturers (2015-2020) Table 10. Manufacturers Erectile Dysfunction Drugs Sales Sites and Area Served Table 11. Manufacturers Erectile Dysfunction Drugs Product Types Table 12. Global Erectile Dysfunction Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Erectile Dysfunction Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Erectile Dysfunction Drugs as of 2019) Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Erectile Dysfunction Drugs Players Table 16. Global Erectile Dysfunction Drugs Sales (M Pill) by Region (2015-2020) Table 17. Global Erectile Dysfunction Drugs Sales Market Share by Region (2015-2020) Table 18. Global Erectile Dysfunction Drugs Revenue (Million US$) by Region (2015-2020) Table 19. Global Erectile Dysfunction Drugs Revenue Market Share by Region (2015-2020) Table 20. North America Erectile Dysfunction Drugs Sales by Country (2015-2020) (M Pill) Table 21. North America Erectile Dysfunction Drugs Sales Market Share by Country (2015-2020) Table 22. North America Erectile Dysfunction Drugs Revenue by Country (2015-2020) (US$ Million) Table 23. North America Erectile Dysfunction Drugs Revenue Market Share by Country (2015-2020) Table 24. Europe Erectile Dysfunction Drugs Sales by Country (2015-2020) (M Pill) Table 25. Europe Erectile Dysfunction Drugs Sales Market Share by Country (2015-2020) Table 26. Europe Erectile Dysfunction Drugs Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Erectile Dysfunction Drugs Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Erectile Dysfunction Drugs Sales by Region (2015-2020) (M Pill) Table 29. Asia Pacific Erectile Dysfunction Drugs Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Erectile Dysfunction Drugs Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Erectile Dysfunction Drugs Revenue Market Share by Region (2015-2020) Table 32. Latin America Erectile Dysfunction Drugs Sales by Country (2015-2020) (M Pill) Table 33. Latin America Erectile Dysfunction Drugs Sales Market Share by Country (2015-2020) Table 34. Latin America Erectile Dysfunction Drugs Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Erectile Dysfunction Drugs Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Erectile Dysfunction Drugs Sales by Country (2015-2020) (M Pill) Table 37. Middle East and Africa Erectile Dysfunction Drugs Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Erectile Dysfunction Drugs Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Erectile Dysfunction Drugs Revenue Market Share by Country (2015-2020) Table 40. Global Erectile Dysfunction Drugs Sales (M Pill) by Type (2015-2020) Table 41. Global Erectile Dysfunction Drugs Sales Share by Type (2015-2020) Table 42. Global Erectile Dysfunction Drugs Revenue (Million US$) by Type (2015-2020) Table 43. Global Erectile Dysfunction Drugs Revenue Share by Type (2015-2020) Table 44. Global Erectile Dysfunction Drugs Price (USD/Pill) by Type (2015-2020) Table 45. Global Erectile Dysfunction Drugs Sales (M Pill) by Application (2015-2020) Table 46. Global Erectile Dysfunction Drugs Sales Market Share by Application (2015-2020) Table 47. Global Erectile Dysfunction Drugs Sales Growth Rate by Application (2015-2020) Table 48. Eli Lilly Erectile Dysfunction Drugs Corporation Information Table 49. Eli Lilly Description and Business Overview Table 50. Eli Lilly Erectile Dysfunction Drugs Sales (M Pill), Revenue (Million US$), Price (USD/Pill) and Gross Margin (2015-2020) Table 51. Eli Lilly Main Product Table 52. Eli Lilly Recent Development Table 53. Pfizer Erectile Dysfunction Drugs Corporation Information Table 54. Pfizer Corporation Information Table 55. Pfizer Erectile Dysfunction Drugs Sales (M Pill), Revenue (Million US$), Price (USD/Pill) and Gross Margin (2015-2020) Table 56. Pfizer Main Product Table 57. Pfizer Recent Development Table 58. Bayer Erectile Dysfunction Drugs Corporation Information Table 59. Bayer Corporation Information Table 60. Bayer Erectile Dysfunction Drugs Sales (M Pill), Revenue (Million US$), Price (USD/Pill) and Gross Margin (2015-2020) Table 61. Bayer Main Product Table 62. Bayer Recent Development Table 63. BaiYunShan General Factory Erectile Dysfunction Drugs Corporation Information Table 64. BaiYunShan General Factory Corporation Information Table 65. BaiYunShan General Factory Erectile Dysfunction Drugs Sales (M Pill), Revenue (Million US$), Price (USD/Pill) and Gross Margin (2015-2020) Table 66. BaiYunShan General Factory Main Product Table 67. BaiYunShan General Factory Recent Development Table 68. S.K. Chemicals Erectile Dysfunction Drugs Corporation Information Table 69. S.K. Chemicals Corporation Information Table 70. S.K. Chemicals Erectile Dysfunction Drugs Sales (M Pill), Revenue (Million US$), Price (USD/Pill) and Gross Margin (2015-2020) Table 71. S.K. Chemicals Main Product Table 72. S.K. Chemicals Recent Development Table 73. Teva Pharma Erectile Dysfunction Drugs Corporation Information Table 74. Teva Pharma Corporation Information Table 75. Teva Pharma Erectile Dysfunction Drugs Sales (M Pill), Revenue (Million US$), Price (USD/Pill) and Gross Margin (2015-2020) Table 76. Teva Pharma Main Product Table 77. Teva Pharma Recent Development Table 78. Dong-A ST Erectile Dysfunction Drugs Corporation Information Table 79. Dong-A ST Corporation Information Table 80. Dong-A ST Erectile Dysfunction Drugs Sales (M Pill), Revenue (Million US$), Price (USD/Pill) and Gross Margin (2015-2020) Table 81. Dong-A ST Main Product Table 82. Dong-A ST Recent Development Table 83. Metuchen Pharma Erectile Dysfunction Drugs Corporation Information Table 84. Metuchen Pharma Corporation Information Table 85. Metuchen Pharma Erectile Dysfunction Drugs Sales (M Pill), Revenue (Million US$), Price (USD/Pill) and Gross Margin (2015-2020) Table 86. Metuchen Pharma Main Product Table 87. Metuchen Pharma Recent Development Table 88. Seoul Pharma Erectile Dysfunction Drugs Corporation Information Table 89. Seoul Pharma Corporation Information Table 90. Seoul Pharma Erectile Dysfunction Drugs Sales (M Pill), Revenue (Million US$), Price (USD/Pill) and Gross Margin (2015-2020) Table 91. Seoul Pharma Main Product Table 92. Seoul Pharma Recent Development Table 93. CSBIO. Erectile Dysfunction Drugs Corporation Information Table 94. CSBIO. Corporation Information Table 95. CSBIO. Erectile Dysfunction Drugs Sales (M Pill), Revenue (Million US$), Price (USD/Pill) and Gross Margin (2015-2020) Table 96. CSBIO. Main Product Table 97. CSBIO. Recent Development Table 98. Sales Base and Market Concentration Rate of Raw Material Table 99. Key Suppliers of Raw Materials Table 100. Erectile Dysfunction Drugs Distributors List Table 101. Erectile Dysfunction Drugs Customers List Table 102. Market Key Trends Table 103. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 104. Key Challenges Table 105. Global Erectile Dysfunction Drugs Sales (M Pill) Forecast by Type (2021-2026) Table 106. Global Erectile Dysfunction Drugs Sales Market Share Forecast by Type (2021-2026) Table 107. Global Erectile Dysfunction Drugs Revenue (Million US$) Forecast by Type (2021-2026) Table 108. Global Erectile Dysfunction Drugs Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 109. Global Erectile Dysfunction Drugs Sales (M Pill) Forecast by Application (2021-2026) Table 110. Global Erectile Dysfunction Drugs Revenue (Million US$) Forecast by Application (2021-2026) Table 111. Global Erectile Dysfunction Drugs Sales (M Pill) Forecast by Region (2021-2026) Table 112. Global Erectile Dysfunction Drugs Sales Market Share Forecast by Region (2021-2026) Table 113. Global Erectile Dysfunction Drugs Revenue Forecast by Region (2021-2026) (US$ Million) Table 114. Global Erectile Dysfunction Drugs Revenue Market Share Forecast by Region (2021-2026) Table 115. Research Programs/Design for This Report Table 116. Key Data Information from Secondary Sources Table 117. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Erectile Dysfunction Drugs Figure 2. Global Erectile Dysfunction Drugs Sales Market Share by Type: 2020 VS 2026 Figure 3. Sildenafil Product Picture Figure 4. Tadalafil Product Picture Figure 5. Others Product Picture Figure 6. Global Erectile Dysfunction Drugs Consumption Market Share by Application: 2020 VS 2026 Figure 7. Hospital Pharmacies Figure 8. Private Clinics Figure 9. Retail Pharmacies Figure 10. E-Commerce (B2B) Figure 11. E-Commerce (B2C) Figure 12. Global Erectile Dysfunction Drugs Market Size 2015-2026 (US$ Million) Figure 13. Global Erectile Dysfunction Drugs Sales Capacity (M Pill) (2015-2026) Figure 14. Global Erectile Dysfunction Drugs Market Size Market Share by Region: 2020 Versus 2026 Figure 15. Erectile Dysfunction Drugs Sales Share by Manufacturers in 2020 Figure 16. Global Erectile Dysfunction Drugs Revenue Share by Manufacturers in 2019 Figure 17. The Global 5 and 10 Largest Players: Market Share by Erectile Dysfunction Drugs Revenue in 2019 Figure 18. Erectile Dysfunction Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 19. Global Erectile Dysfunction Drugs Sales Market Share by Region (2015-2020) Figure 20. Global Erectile Dysfunction Drugs Sales Market Share by Region in 2019 Figure 21. Global Erectile Dysfunction Drugs Revenue Market Share by Region (2015-2020) Figure 22. Global Erectile Dysfunction Drugs Revenue Market Share by Region in 2019 Figure 23. North America Erectile Dysfunction Drugs Sales Market Share by Country in 2019 Figure 24. North America Erectile Dysfunction Drugs Revenue Market Share by Country in 2019 Figure 25. U.S. Erectile Dysfunction Drugs Sales Growth Rate (2015-2020) (M Pill) Figure 26. U.S. Erectile Dysfunction Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 27. Canada Erectile Dysfunction Drugs Sales Growth Rate (2015-2020) (M Pill) Figure 28. Canada Erectile Dysfunction Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 29. Europe Erectile Dysfunction Drugs Sales Market Share by Country in 2019 Figure 30. Europe Erectile Dysfunction Drugs Revenue Market Share by Country in 2019 Figure 31. Germany Erectile Dysfunction Drugs Sales Growth Rate (2015-2020) (M Pill) Figure 32. Germany Erectile Dysfunction Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 33. France Erectile Dysfunction Drugs Sales Growth Rate (2015-2020) (M Pill) Figure 34. France Erectile Dysfunction Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 35. U.K. Erectile Dysfunction Drugs Sales Growth Rate (2015-2020) (M Pill) Figure 36. U.K. Erectile Dysfunction Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 37. Italy Erectile Dysfunction Drugs Sales Growth Rate (2015-2020) (M Pill) Figure 38. Italy Erectile Dysfunction Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 39. Russia Erectile Dysfunction Drugs Sales Growth Rate (2015-2020) (M Pill) Figure 40. Russia Erectile Dysfunction Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 41. Asia Pacific Erectile Dysfunction Drugs Sales Market Share by Region in 2019 Figure 42. Asia Pacific Erectile Dysfunction Drugs Revenue Market Share by Region in 2019 Figure 43. China Erectile Dysfunction Drugs Sales Growth Rate (2015-2020) (M Pill) Figure 44. China Erectile Dysfunction Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. Japan Erectile Dysfunction Drugs Sales Growth Rate (2015-2020) (M Pill) Figure 46. Japan Erectile Dysfunction Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 47. South Korea Erectile Dysfunction Drugs Sales Growth Rate (2015-2020) (M Pill) Figure 48. South Korea Erectile Dysfunction Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. India Erectile Dysfunction Drugs Sales Growth Rate (2015-2020) (M Pill) Figure 50. India Erectile Dysfunction Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. Australia Erectile Dysfunction Drugs Sales Growth Rate (2015-2020) (M Pill) Figure 52. Australia Erectile Dysfunction Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. Taiwan Erectile Dysfunction Drugs Sales Growth Rate (2015-2020) (M Pill) Figure 54. Taiwan Erectile Dysfunction Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Indonesia Erectile Dysfunction Drugs Sales Growth Rate (2015-2020) (M Pill) Figure 56. Indonesia Erectile Dysfunction Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Thailand Erectile Dysfunction Drugs Sales Growth Rate (2015-2020) (M Pill) Figure 58. Thailand Erectile Dysfunction Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Malaysia Erectile Dysfunction Drugs Sales Growth Rate (2015-2020) (M Pill) Figure 60. Malaysia Erectile Dysfunction Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 61. Philippines Erectile Dysfunction Drugs Sales Growth Rate (2015-2020) (M Pill) Figure 62. Philippines Erectile Dysfunction Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 63. Vietnam Erectile Dysfunction Drugs Sales Growth Rate (2015-2020) (M Pill) Figure 64. Vietnam Erectile Dysfunction Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 65. Latin America Erectile Dysfunction Drugs Sales Market Share by Country in 2019 Figure 66. Latin America Erectile Dysfunction Drugs Revenue Market Share by Country in 2019 Figure 67. Mexico Erectile Dysfunction Drugs Sales Growth Rate (2015-2020) (M Pill) Figure 68. Mexico Erectile Dysfunction Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. Brazil Erectile Dysfunction Drugs Sales Growth Rate (2015-2020) (M Pill) Figure 70. Brazil Erectile Dysfunction Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 71. Argentina Erectile Dysfunction Drugs Sales Growth Rate (2015-2020) (M Pill) Figure 72. Argentina Erectile Dysfunction Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 73. Middle East and Africa Erectile Dysfunction Drugs Sales Market Share by Country in 2019 Figure 74. Middle East and Africa Erectile Dysfunction Drugs Revenue Market Share by Country in 2019 Figure 75. Turkey Erectile Dysfunction Drugs Sales Growth Rate (2015-2020) (M Pill) Figure 76. Turkey Erectile Dysfunction Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. Saudi Arabia Erectile Dysfunction Drugs Sales Growth Rate (2015-2020) (M Pill) Figure 78. Saudi Arabia Erectile Dysfunction Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 79. U.A.E Erectile Dysfunction Drugs Sales Growth Rate (2015-2020) (M Pill) Figure 80. U.A.E Erectile Dysfunction Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 81. Sales Market Share of Erectile Dysfunction Drugs by Type (2015-2020) Figure 82. Sales Market Share of Erectile Dysfunction Drugs by Type in 2019 Figure 83. Revenue Share of Erectile Dysfunction Drugs by Type (2015-2020) Figure 84. Revenue Market Share of Erectile Dysfunction Drugs by Type in 2019 Figure 85. Global Erectile Dysfunction Drugs Sales Growth by Type (2015-2020) (M Pill) Figure 86. Global Erectile Dysfunction Drugs Sales Market Share by Application (2015-2020) Figure 87. Global Erectile Dysfunction Drugs Sales Market Share by Application in 2019 Figure 88. Global Revenue Share of Erectile Dysfunction Drugs by Application (2015-2020) Figure 89. Global Revenue Share of Erectile Dysfunction Drugs by Application in 2020 Figure 90. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018 Figure 91. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. Bayer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. BaiYunShan General Factory Total Revenue (US$ Million): 2019 Compared with 2018 Figure 94. S.K. Chemicals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 95. Teva Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 96. Dong-A ST Total Revenue (US$ Million): 2019 Compared with 2018 Figure 97. Metuchen Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 98. Seoul Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 99. CSBIO. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 100. Price Trend of Key Raw Materials Figure 101. Manufacturing Cost Structure of Erectile Dysfunction Drugs Figure 102. Manufacturing Process Analysis of Erectile Dysfunction Drugs Figure 103. Erectile Dysfunction Drugs Industrial Chain Analysis Figure 104. Channels of Distribution Figure 105. Distributors Profiles Figure 106. Porter's Five Forces Analysis Figure 107. North America Erectile Dysfunction Drugs Sales (M Pill) and Growth Rate Forecast (2021-2026) Figure 108. North America Erectile Dysfunction Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 109. Europe Erectile Dysfunction Drugs Sales (M Pill) and Growth Rate Forecast (2021-2026) Figure 110. Europe Erectile Dysfunction Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 111. Latin America Erectile Dysfunction Drugs Sales (M Pill) and Growth Rate Forecast (2021-2026) Figure 112. Latin America Erectile Dysfunction Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 113. Middle East and Africa Erectile Dysfunction Drugs Sales (M Pill) and Growth Rate Forecast (2021-2026) Figure 114. Middle East and Africa Erectile Dysfunction Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 115. Asia Pacific Erectile Dysfunction Drugs Sales (M Pill) and Growth Rate Forecast (2021-2026) Figure 116. Asia Pacific Erectile Dysfunction Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 117. Bottom-up and Top-down Approaches for This Report Figure 118. Data Triangulation Figure 119. Key Executives Interviewed

Eli Lilly Pfizer Bayer BaiYunShan General Factory S.K. Chemicals Teva Pharma Dong-A ST Metuchen Pharma Seoul Pharma CSBIO.